IDF Diabetes Atlas 9th edition 2019
•Download as PPTX, PDF•
0 likes•165 views
About the IDF Diabetes Atlas The IDF Diabetes Atlas is an authoritative resource on the global impact of diabetes. First published in 2000, it is updated periodically by IDF in collaboration with experts from around the world and contains data on diabetes prevalence, mortality and expenditure on global, regional and national levels. The IDF Diabetes Atlas draws attention to the importance and growing impact of diabetes in all countries and IDF Regions. www.diabetesatlas.org
Report
Share
Report
Share
Recommended
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Cardiologists and diabetes.Target organs and action mechanism of antidiabetic drugs.Cardiovascular Outcome Trials
( CVOTs ) in Diabetes.Completed and ongoing CVOTs in type 2 diabetes.Diabetes Medications
and
Cardiovascular Impact.Recommendations for management of diabetes
Cardiovascular safety of anti-diabetic drugs.
SGLT2I The paradigm change in diabetes management
Just like ARNI, SGLT2I have changed the face of diabetes management and they have a good profile in multimodality management because of pleiotropic effects
Practical Guidelines Diabetes and Ramadan (DAR)
The IDF-DAR Practical Guidelines provide recommendations for healthcare professionals to help patients with diabetes safely participate in Ramadan fasting. Ramadan fasting is compulsory for healthy adult Muslims but exemptions exist for those with medical conditions like diabetes. The number of Muslims with diabetes is increasing worldwide as diabetes rises globally. Many patients still wish to fast during Ramadan against medical advice, so guidelines are needed to minimize health risks. The guidelines aim to educate healthcare workers without extensive experience in this area to properly advise their diabetic patients observing Ramadan.
Weight Management in Type 2 Diabetes: 2015
1) Weight loss is an important goal in managing type 2 diabetes, but lifestyle interventions alone often do not lead to sufficient weight loss for many patients.
2) Several antidiabetes drug classes have potential for weight loss, including GLP-1 receptor agonists, SGLT2 inhibitors, amylin analog pramlintide, and some obesity drugs approved for weight management like orlistat.
3) These drugs provide glycemic control benefits and varying degrees of weight loss, but also come with gastrointestinal side effects in some cases that require management.
Diabetes in Ramadan guidelines
This document provides guidelines for healthcare professionals on managing diabetes during Ramadan fasting. It aims to give practical recommendations to minimize health risks for Muslims with diabetes who choose to fast. The guidelines cover topics like epidemiology, physiology, risk assessment, nutrition, medication adjustment, and implementing recommendations. They emphasize individualization and education as part of a diabetes management plan. The number of Muslims with diabetes is rising globally and most fast during Ramadan, so ensuring optimal care is important. More research is still needed, but these guidelines aim to provide immediate guidance for patients fasting in coming years.
Carmelina
This document discusses the challenges of managing diabetes in patients with chronic kidney disease (CKD). It notes that diabetes is a leading cause of CKD progression and that CKD increases mortality risk in diabetes patients. Managing glucose levels in CKD patients is difficult due to risks of hypoglycemia from insulin clearance issues and need to adjust oral medications for kidney function. The CARMELINA trial demonstrated the renal safety of the DPP-4 inhibitor linagliptin in high cardio-renal risk patients, showing no increase in sustained decrease in eGFR or other renal outcomes compared to placebo over 2 years.
Prediabetes
This document discusses pre-diabetes, including its definition, prevalence, health risks, diagnostic criteria, and treatment options. Some key points:
- Pre-diabetes is when blood glucose levels are higher than normal but not high enough for a diagnosis of diabetes. Left untreated, pre-diabetes often progresses to type 2 diabetes.
- Studies like the Diabetes Prevention Program showed that modest lifestyle changes like 5-10% weight loss and moderate physical activity can prevent or delay the onset of diabetes in those with pre-diabetes.
- In addition to lifestyle changes, pharmacologic treatments like metformin may be considered for high-risk individuals to prevent the progression from pre-diabetes to diabetes. However,
Diabetes Prevention Powerpoint
Type 2 diabetes is a condition where the body cannot effectively control blood sugar levels. It develops over many years as the body becomes resistant to the effects of insulin. Prediabetes occurs when blood sugar levels are higher than normal but not high enough to be diagnosed as diabetes. The best way to prevent type 2 diabetes is through lifestyle changes like regular physical activity and modest weight loss. Maintaining a healthy lifestyle can significantly reduce risk of developing diabetes and its serious health complications.
Recommended
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Cardiologists and diabetes.Target organs and action mechanism of antidiabetic drugs.Cardiovascular Outcome Trials
( CVOTs ) in Diabetes.Completed and ongoing CVOTs in type 2 diabetes.Diabetes Medications
and
Cardiovascular Impact.Recommendations for management of diabetes
Cardiovascular safety of anti-diabetic drugs.
SGLT2I The paradigm change in diabetes management
Just like ARNI, SGLT2I have changed the face of diabetes management and they have a good profile in multimodality management because of pleiotropic effects
Practical Guidelines Diabetes and Ramadan (DAR)
The IDF-DAR Practical Guidelines provide recommendations for healthcare professionals to help patients with diabetes safely participate in Ramadan fasting. Ramadan fasting is compulsory for healthy adult Muslims but exemptions exist for those with medical conditions like diabetes. The number of Muslims with diabetes is increasing worldwide as diabetes rises globally. Many patients still wish to fast during Ramadan against medical advice, so guidelines are needed to minimize health risks. The guidelines aim to educate healthcare workers without extensive experience in this area to properly advise their diabetic patients observing Ramadan.
Weight Management in Type 2 Diabetes: 2015
1) Weight loss is an important goal in managing type 2 diabetes, but lifestyle interventions alone often do not lead to sufficient weight loss for many patients.
2) Several antidiabetes drug classes have potential for weight loss, including GLP-1 receptor agonists, SGLT2 inhibitors, amylin analog pramlintide, and some obesity drugs approved for weight management like orlistat.
3) These drugs provide glycemic control benefits and varying degrees of weight loss, but also come with gastrointestinal side effects in some cases that require management.
Diabetes in Ramadan guidelines
This document provides guidelines for healthcare professionals on managing diabetes during Ramadan fasting. It aims to give practical recommendations to minimize health risks for Muslims with diabetes who choose to fast. The guidelines cover topics like epidemiology, physiology, risk assessment, nutrition, medication adjustment, and implementing recommendations. They emphasize individualization and education as part of a diabetes management plan. The number of Muslims with diabetes is rising globally and most fast during Ramadan, so ensuring optimal care is important. More research is still needed, but these guidelines aim to provide immediate guidance for patients fasting in coming years.
Carmelina
This document discusses the challenges of managing diabetes in patients with chronic kidney disease (CKD). It notes that diabetes is a leading cause of CKD progression and that CKD increases mortality risk in diabetes patients. Managing glucose levels in CKD patients is difficult due to risks of hypoglycemia from insulin clearance issues and need to adjust oral medications for kidney function. The CARMELINA trial demonstrated the renal safety of the DPP-4 inhibitor linagliptin in high cardio-renal risk patients, showing no increase in sustained decrease in eGFR or other renal outcomes compared to placebo over 2 years.
Prediabetes
This document discusses pre-diabetes, including its definition, prevalence, health risks, diagnostic criteria, and treatment options. Some key points:
- Pre-diabetes is when blood glucose levels are higher than normal but not high enough for a diagnosis of diabetes. Left untreated, pre-diabetes often progresses to type 2 diabetes.
- Studies like the Diabetes Prevention Program showed that modest lifestyle changes like 5-10% weight loss and moderate physical activity can prevent or delay the onset of diabetes in those with pre-diabetes.
- In addition to lifestyle changes, pharmacologic treatments like metformin may be considered for high-risk individuals to prevent the progression from pre-diabetes to diabetes. However,
Diabetes Prevention Powerpoint
Type 2 diabetes is a condition where the body cannot effectively control blood sugar levels. It develops over many years as the body becomes resistant to the effects of insulin. Prediabetes occurs when blood sugar levels are higher than normal but not high enough to be diagnosed as diabetes. The best way to prevent type 2 diabetes is through lifestyle changes like regular physical activity and modest weight loss. Maintaining a healthy lifestyle can significantly reduce risk of developing diabetes and its serious health complications.
Diabetic dyslipidemia
Cardiovascular disease - more common in diabetic patients than in the general population
Dyslipidemia – common in patients with both types of diabetes.
Aggressive lipid treatment goals have been recommended for patients with type 2 diabetes
Diabetic Dyslipidemia is highly prevalent in the Indian diabetic population
Dyslipidemia in diabetes differs significantly with hypertriglyceridemia and small dense LDL-C
ADA 2022.pptx
This document provides guidelines for classifying and diagnosing different types of diabetes. It discusses five general categories: type 1 diabetes, type 2 diabetes, specific types due to other causes like monogenic diabetes, gestational diabetes mellitus, and diabetes related to other conditions like cystic fibrosis or organ transplantation. For each type, it provides recommendations for screening and diagnosis, including which tests to use and at what age or time periods patients should be tested. The guidelines are meant to help ensure accurate diagnosis and avoid missed or misdiagnoses.
Diabetes Remission and Prevention
This document summarizes key findings from the IDF Diabetes Atlas 2021:
1) An estimated 537 million adults aged 20-79 have diabetes globally in 2021, representing 1 in 10 adults. 6.7 million deaths are attributed to diabetes each year.
2) The top 10 countries for number of adults with diabetes are China, India, USA, Brazil, Pakistan, Indonesia, Mexico, Egypt, Italy, and Bangladesh. The top countries for diabetes healthcare expenditure are USA, China, Japan, Germany, and India.
3) Diabetes prevalence is increasing worldwide, with the majority (75%) of people with diabetes living in low and middle income countries. Cardiovascular disease is the leading cause of death for people
Global Continuous Glucose Monitoring System | Forecast 2015-2021
Global Continuous Glucose Monitoring System | Forecast 2015-2021 Occams Business Research & Consulting
CGM Market Report Presentation by [Occams Business Research] Market Analysis, Size, Growth, Share, opportunities Forecasts 2015-2021 Dapagliflozin Ib CKD.pptx
Dapagliflozin demonstrated clear treatment benefits for cardiovascular, kidney, and mortality outcomes in patients with chronic kidney disease (CKD), regardless of the presence of diabetes. It provides glomerular protection, limits proteinuria and kidney damage, and slows the decline of glomerular filtration rate in CKD patients. The DAPA-CKD trial found that dapagliflozin reduced the risk of end-stage renal disease or death from renal causes compared to placebo in CKD patients with and without type 2 diabetes. Dapagliflozin is indicated for the treatment of CKD up to stage III and was well tolerated with a low rate of treatment discontinuation.
Fasting with Diabetes by Dr Shahjada Selim
- Fasting during Ramadan presents risks for those with diabetes like hypoglycemia and hyperglycemia due to changes in eating, sleeping, and medication patterns.
- Diabetic patients should be categorized into very high, high, or moderate/low risk groups based on their health conditions and diabetes control to determine if fasting is safe.
- Those at very high or high risk of complications from fasting, such as those with severe diabetes or other health issues, should not fast during Ramadan. Others may fast with proper education, medical guidance, and glucose monitoring.
Management of diabetes in elderly
This document discusses the management of diabetes in elderly patients. It notes that diabetes prevalence is increasing globally and is especially prevalent in aging populations due to increased complexity, comorbidities, and risk of functional decline. Proper management of elderly diabetes requires individualized, holistic care plans focused on safety, risk minimization, and maintaining quality of life. Key aspects of care include education, nutrition, exercise, medication management, screening and prevention of complications, and management of comorbidities like cardiovascular disease.
IMEglimin .pptx
Imeglimin is a novel anti-diabetic drug that targets mitochondrial dysfunction, a key pathological basis for diabetes. It acts on the pancreas to preserve insulin secretion and on tissues to enhance insulin action. Imeglimin has shown efficacy in reducing HbA1c and fasting glucose when used alone or in combination with other drugs. It offers advantages over existing treatments by improving mitochondrial function without inhibiting respiration and has shown protective effects on organs like the kidney and heart. The risk of lactic acidosis may be lower compared to metformin due to distinct mechanisms of action.
The use of vildagliptin in patients with type 2 diabetes with renal impairment
The use of vildagliptin in patients with type 2 diabetes with renal impairment
By Dr. Usama Ragab Youssif
Agenda
----------
Case presentation
Diabetes and CKD: What is the problem
Drug treatment in patient with CKD: choice of treatment
Vildagliptin in mild renal impairment
Vildagliptin in moderate and severe renal impairment
Vildagliptin in ESRD (patients on HD)
Vildagliptin in kidney transplant patients with NODAT
Final bottom-line
Cardiovascular Risk in Diabetes
Cardiovascular disease is a major risk for those with diabetes.
1) Studies like the Framingham Heart Study and UKPDS found diabetes to be a significant risk factor for cardiovascular mortality and events like heart attacks.
2) Having diabetes poses similar risks as having a heart attack, with endothelial dysfunction, dyslipidemia, and other factors increasing cardiovascular risks.
3) Lifestyle changes like diet, exercise, weight loss and optimal control of blood pressure, cholesterol and blood sugars can help prevent premature cardiovascular events for those with diabetes.
Management of Diabetes in the Elderly
This document discusses considerations for managing diabetes in the elderly. It notes that glycemic goals must be tailored to individual patients based on their health status and functional ability. Hypoglycemia is a major risk in the elderly, and medications like sulfonylureas and insulin carry higher risks. Metformin must be used cautiously. Other agents like DPP-4 inhibitors and GLP-1 agonists have lower risks. Insulin may be needed but regimens must account for risks of non-adherence and hypoglycemia. The document emphasizes starting with lifestyle changes in prediabetes and selecting treatments carefully based on the strongest evidence while avoiding overtreatment.
Diabetes
Diabetes is a group of metabolic diseases characterized by high blood sugar levels. There are several types of diabetes including type 1 caused by the immune system destroying insulin-producing cells, type 2 caused by insulin resistance or lack of insulin production, and gestational diabetes during pregnancy. Symptoms include increased thirst, hunger, urination and fatigue. Diabetes is treated through medicines, diet, exercise and controlling blood sugar, blood pressure and cholesterol to reduce complications like kidney disease, eye disease and heart attack. Diabetes affects quality of life and has a significant societal impact through its associated healthcare costs and disability.
Hypertension management 2018
This lecture presents the 1-Updated recommendations regarding definition and proper diagnosis of HTN. 2-Updated guidelines for threshold of BP to start treatment and targets of treatment. 3- Updated recommendations on CV risk assessment and management. 4-Hypertension and comorbidities: updated guidelines
Diabetes management in ramadan
Diabetes management in Ramadan presents medical challenges as many Muslim patients with diabetes insist on fasting during Ramadan. The document discusses:
1) Major risks of fasting including hypoglycemia, hyperglycemia, diabetic ketoacidosis, and dehydration.
2) Categories of diabetes risk for fasting - very high, high, moderate, low.
3) Recommendations for diabetes management during Ramadan including adjusting medications, monitoring blood sugar, nutrition, exercise and breaking the fast if complications occur.
4) Studies showing education programs can help improve diabetes control and reduce risks when fasting during Ramadan.
MNT for DM by DrSelim
This document discusses medical nutrition therapy for diabetes. It outlines the major components of diabetes treatment as management of diabetes through nutrition recommendations and interventions. It describes expected outcomes of medical nutrition therapy for diabetes such as reductions in A1C and LDL-C. The document discusses nutrition therapy strategies for type 1 and type 2 diabetes, including carbohydrate intake, fiber, sweeteners, and glycemic index. It provides guidelines on integrating insulin therapy with dietary and activity patterns and adjusting insulin doses based on carbohydrate intake.
Global Prevalence of Diabetes and IDF for managing Type 2 Diabetes in Primar...
Global Prevalence of Diabetes and IDF for managing Type 2 Diabetes in Primar...Bangabandhu Sheikh Mujib Medical University
Global Prevalence of Diabetes and IDF Clinical Practice Recommendations for managing Type 2 Diabetes in Primary Care by Dr Shahjada Selimfacts and myths about diabetes
The document discusses the myths and facts about diabetes diets. It explains that diabetics do not need to strictly cut out all sweets and enjoyments, but rather can incorporate moderation and make substitutes. A diabetic diet is generally the same as a healthy diet, based on whole grains, vegetables, fruits and moderate fat, salt and sugar. With the right information about balanced nutrition and lifestyle, one need not feel they must radically change their life due to a diabetes diagnosis.
Updates of Diabetes Management by Dr Selim
This document provides an overview of diabetes management guidelines from the American Diabetes Association. It defines diabetes, classifies the different types, and outlines diagnostic criteria. It discusses the major components of treatment including medical nutrition therapy, physical activity, smoking cessation, comprehensive medical evaluation, glycemic targets, glucose monitoring, and pharmacological therapies. Glycemic goals and treatment approaches are presented for both type 1 and type 2 diabetes in adults and children.
Diabetes mellitus and vascular disease 2022 FINALD.pptx
Diabetes is strongly linked to cardiovascular disease through several mechanisms. It increases the risk of both macrovascular and microvascular complications. Treatment aims to control blood sugar and modify risk factors like smoking, physical inactivity, and high cholesterol to prevent vascular disease and related mortality. For those with existing vascular problems, medications that have shown cardiovascular benefits like SGLT2 inhibitors and GLP1 agonists may be recommended. Lifestyle changes and medical therapies can both help reduce cardiovascular risks in people with diabetes.
The Truth About Diabetes: Myths versus Facts
Think you know the facts about diabetes? See if you can distinguish which of these common perceptions are fact.
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
More Related Content
What's hot
Diabetic dyslipidemia
Cardiovascular disease - more common in diabetic patients than in the general population
Dyslipidemia – common in patients with both types of diabetes.
Aggressive lipid treatment goals have been recommended for patients with type 2 diabetes
Diabetic Dyslipidemia is highly prevalent in the Indian diabetic population
Dyslipidemia in diabetes differs significantly with hypertriglyceridemia and small dense LDL-C
ADA 2022.pptx
This document provides guidelines for classifying and diagnosing different types of diabetes. It discusses five general categories: type 1 diabetes, type 2 diabetes, specific types due to other causes like monogenic diabetes, gestational diabetes mellitus, and diabetes related to other conditions like cystic fibrosis or organ transplantation. For each type, it provides recommendations for screening and diagnosis, including which tests to use and at what age or time periods patients should be tested. The guidelines are meant to help ensure accurate diagnosis and avoid missed or misdiagnoses.
Diabetes Remission and Prevention
This document summarizes key findings from the IDF Diabetes Atlas 2021:
1) An estimated 537 million adults aged 20-79 have diabetes globally in 2021, representing 1 in 10 adults. 6.7 million deaths are attributed to diabetes each year.
2) The top 10 countries for number of adults with diabetes are China, India, USA, Brazil, Pakistan, Indonesia, Mexico, Egypt, Italy, and Bangladesh. The top countries for diabetes healthcare expenditure are USA, China, Japan, Germany, and India.
3) Diabetes prevalence is increasing worldwide, with the majority (75%) of people with diabetes living in low and middle income countries. Cardiovascular disease is the leading cause of death for people
Global Continuous Glucose Monitoring System | Forecast 2015-2021
Global Continuous Glucose Monitoring System | Forecast 2015-2021 Occams Business Research & Consulting
CGM Market Report Presentation by [Occams Business Research] Market Analysis, Size, Growth, Share, opportunities Forecasts 2015-2021 Dapagliflozin Ib CKD.pptx
Dapagliflozin demonstrated clear treatment benefits for cardiovascular, kidney, and mortality outcomes in patients with chronic kidney disease (CKD), regardless of the presence of diabetes. It provides glomerular protection, limits proteinuria and kidney damage, and slows the decline of glomerular filtration rate in CKD patients. The DAPA-CKD trial found that dapagliflozin reduced the risk of end-stage renal disease or death from renal causes compared to placebo in CKD patients with and without type 2 diabetes. Dapagliflozin is indicated for the treatment of CKD up to stage III and was well tolerated with a low rate of treatment discontinuation.
Fasting with Diabetes by Dr Shahjada Selim
- Fasting during Ramadan presents risks for those with diabetes like hypoglycemia and hyperglycemia due to changes in eating, sleeping, and medication patterns.
- Diabetic patients should be categorized into very high, high, or moderate/low risk groups based on their health conditions and diabetes control to determine if fasting is safe.
- Those at very high or high risk of complications from fasting, such as those with severe diabetes or other health issues, should not fast during Ramadan. Others may fast with proper education, medical guidance, and glucose monitoring.
Management of diabetes in elderly
This document discusses the management of diabetes in elderly patients. It notes that diabetes prevalence is increasing globally and is especially prevalent in aging populations due to increased complexity, comorbidities, and risk of functional decline. Proper management of elderly diabetes requires individualized, holistic care plans focused on safety, risk minimization, and maintaining quality of life. Key aspects of care include education, nutrition, exercise, medication management, screening and prevention of complications, and management of comorbidities like cardiovascular disease.
IMEglimin .pptx
Imeglimin is a novel anti-diabetic drug that targets mitochondrial dysfunction, a key pathological basis for diabetes. It acts on the pancreas to preserve insulin secretion and on tissues to enhance insulin action. Imeglimin has shown efficacy in reducing HbA1c and fasting glucose when used alone or in combination with other drugs. It offers advantages over existing treatments by improving mitochondrial function without inhibiting respiration and has shown protective effects on organs like the kidney and heart. The risk of lactic acidosis may be lower compared to metformin due to distinct mechanisms of action.
The use of vildagliptin in patients with type 2 diabetes with renal impairment
The use of vildagliptin in patients with type 2 diabetes with renal impairment
By Dr. Usama Ragab Youssif
Agenda
----------
Case presentation
Diabetes and CKD: What is the problem
Drug treatment in patient with CKD: choice of treatment
Vildagliptin in mild renal impairment
Vildagliptin in moderate and severe renal impairment
Vildagliptin in ESRD (patients on HD)
Vildagliptin in kidney transplant patients with NODAT
Final bottom-line
Cardiovascular Risk in Diabetes
Cardiovascular disease is a major risk for those with diabetes.
1) Studies like the Framingham Heart Study and UKPDS found diabetes to be a significant risk factor for cardiovascular mortality and events like heart attacks.
2) Having diabetes poses similar risks as having a heart attack, with endothelial dysfunction, dyslipidemia, and other factors increasing cardiovascular risks.
3) Lifestyle changes like diet, exercise, weight loss and optimal control of blood pressure, cholesterol and blood sugars can help prevent premature cardiovascular events for those with diabetes.
Management of Diabetes in the Elderly
This document discusses considerations for managing diabetes in the elderly. It notes that glycemic goals must be tailored to individual patients based on their health status and functional ability. Hypoglycemia is a major risk in the elderly, and medications like sulfonylureas and insulin carry higher risks. Metformin must be used cautiously. Other agents like DPP-4 inhibitors and GLP-1 agonists have lower risks. Insulin may be needed but regimens must account for risks of non-adherence and hypoglycemia. The document emphasizes starting with lifestyle changes in prediabetes and selecting treatments carefully based on the strongest evidence while avoiding overtreatment.
Diabetes
Diabetes is a group of metabolic diseases characterized by high blood sugar levels. There are several types of diabetes including type 1 caused by the immune system destroying insulin-producing cells, type 2 caused by insulin resistance or lack of insulin production, and gestational diabetes during pregnancy. Symptoms include increased thirst, hunger, urination and fatigue. Diabetes is treated through medicines, diet, exercise and controlling blood sugar, blood pressure and cholesterol to reduce complications like kidney disease, eye disease and heart attack. Diabetes affects quality of life and has a significant societal impact through its associated healthcare costs and disability.
Hypertension management 2018
This lecture presents the 1-Updated recommendations regarding definition and proper diagnosis of HTN. 2-Updated guidelines for threshold of BP to start treatment and targets of treatment. 3- Updated recommendations on CV risk assessment and management. 4-Hypertension and comorbidities: updated guidelines
Diabetes management in ramadan
Diabetes management in Ramadan presents medical challenges as many Muslim patients with diabetes insist on fasting during Ramadan. The document discusses:
1) Major risks of fasting including hypoglycemia, hyperglycemia, diabetic ketoacidosis, and dehydration.
2) Categories of diabetes risk for fasting - very high, high, moderate, low.
3) Recommendations for diabetes management during Ramadan including adjusting medications, monitoring blood sugar, nutrition, exercise and breaking the fast if complications occur.
4) Studies showing education programs can help improve diabetes control and reduce risks when fasting during Ramadan.
MNT for DM by DrSelim
This document discusses medical nutrition therapy for diabetes. It outlines the major components of diabetes treatment as management of diabetes through nutrition recommendations and interventions. It describes expected outcomes of medical nutrition therapy for diabetes such as reductions in A1C and LDL-C. The document discusses nutrition therapy strategies for type 1 and type 2 diabetes, including carbohydrate intake, fiber, sweeteners, and glycemic index. It provides guidelines on integrating insulin therapy with dietary and activity patterns and adjusting insulin doses based on carbohydrate intake.
Global Prevalence of Diabetes and IDF for managing Type 2 Diabetes in Primar...
Global Prevalence of Diabetes and IDF for managing Type 2 Diabetes in Primar...Bangabandhu Sheikh Mujib Medical University
Global Prevalence of Diabetes and IDF Clinical Practice Recommendations for managing Type 2 Diabetes in Primary Care by Dr Shahjada Selimfacts and myths about diabetes
The document discusses the myths and facts about diabetes diets. It explains that diabetics do not need to strictly cut out all sweets and enjoyments, but rather can incorporate moderation and make substitutes. A diabetic diet is generally the same as a healthy diet, based on whole grains, vegetables, fruits and moderate fat, salt and sugar. With the right information about balanced nutrition and lifestyle, one need not feel they must radically change their life due to a diabetes diagnosis.
Updates of Diabetes Management by Dr Selim
This document provides an overview of diabetes management guidelines from the American Diabetes Association. It defines diabetes, classifies the different types, and outlines diagnostic criteria. It discusses the major components of treatment including medical nutrition therapy, physical activity, smoking cessation, comprehensive medical evaluation, glycemic targets, glucose monitoring, and pharmacological therapies. Glycemic goals and treatment approaches are presented for both type 1 and type 2 diabetes in adults and children.
Diabetes mellitus and vascular disease 2022 FINALD.pptx
Diabetes is strongly linked to cardiovascular disease through several mechanisms. It increases the risk of both macrovascular and microvascular complications. Treatment aims to control blood sugar and modify risk factors like smoking, physical inactivity, and high cholesterol to prevent vascular disease and related mortality. For those with existing vascular problems, medications that have shown cardiovascular benefits like SGLT2 inhibitors and GLP1 agonists may be recommended. Lifestyle changes and medical therapies can both help reduce cardiovascular risks in people with diabetes.
The Truth About Diabetes: Myths versus Facts
Think you know the facts about diabetes? See if you can distinguish which of these common perceptions are fact.
What's hot (20)
Global Continuous Glucose Monitoring System | Forecast 2015-2021
Global Continuous Glucose Monitoring System | Forecast 2015-2021
The use of vildagliptin in patients with type 2 diabetes with renal impairment
The use of vildagliptin in patients with type 2 diabetes with renal impairment
Global Prevalence of Diabetes and IDF for managing Type 2 Diabetes in Primar...
Global Prevalence of Diabetes and IDF for managing Type 2 Diabetes in Primar...
Diabetes mellitus and vascular disease 2022 FINALD.pptx
Diabetes mellitus and vascular disease 2022 FINALD.pptx
Recently uploaded
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
This document outlines policies and procedures for handling narcotic and controlled drugs in NABH accredited hospitals.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation. Identifying Major Symptoms of Slip Disc.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.
Ketone bodies and metabolism-biochemistry
This slide consists of all the topics of ketone . This can be used for exam purpose for writing about Diabetic keto acidosis etc . Thank you
Recently uploaded (20)
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
IDF Diabetes Atlas 9th edition 2019
- 1. Presentation of the new IDF DIABETES ATLAS WORLD DIABETES DAY
- 2. INTRODUCTIN In 2019, IDF estimates that: INTRODUCTION
- 3. Highlights:
- 4. All editions of the Atlas
- 5. Number of people (20-79 years) with diabetes globally and by IDF Region
- 6. Estimates and projections of the global prevalence of diabetes in the 20–79 year age group (millions)
- 7. Number of people (20-79 years) with diabetes, 2019 DIABETES IN ADULTS
- 8. Prevalence of people with diabetes by age and income group (%), 2019
- 9. Number of people with diabetes (20–79 years) living in urban and rural areas, 2019
- 10. Top 10 countries with diabetes (20-79 years) and their health expenditure, 2019
- 11. Number and proportion of adults (20-79 years) with undiagnosed diabetes per region, 2019 UNDIAGNOSED UNDIAGNOSED DIABETES
- 12. Prevalence of impaired glucose tolerance in adults (20–79 years), 2019* *Age-adjusted comparative prevalence IMPAIRED GLUCOSE TOLERANCE
- 13. Number of adults (20-79 years) with impaired glucose tolerance and diabetes (in millions) by IDF Region, 2019
- 14. Prevalence of hyperglycaemia in pregnancy in women (20-49 years) by IDF Region (%), 2019* *Age-adjusted comparative prevalence HYPERGLYCAEMIA IN PREGNANCY
- 15. Number of deaths by age and sex (20-79 years), 2019 MORTALITY
- 16. Proportion of death before the age of 60 years in 2019
- 17. Total diabetes-related health expenditure for adults (20–79 years) with diabetes HEALTH EXPENDITURE
- 18. Total diabetes-related and mean health expenditure per person and per income group, 2019
- 19. Percentage of total health spending allocated to diabetes per region, 2019
- 20. Total diabetes-related health expenditure (USD billion) by age group
- 21. Total diabetes-related health expenditure for adults (20–79 years) with diabetes Age-sex standardised incidence rates (per 100,000 population per annum) of type 1 diabetes in children and adolescents aged 0–14 years, 2019 CHILDREN AND ADOLESCENTS